A detailed history of Casdin Capital, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Casdin Capital, LLC holds 857,904 shares of VCYT stock, worth $29.5 Million. This represents 1.6% of its overall portfolio holdings.

Number of Shares
857,904
Previous 857,904 -0.0%
Holding current value
$29.5 Million
Previous $18.6 Million -0.0%
% of portfolio
1.6%
Previous 1.61%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$21.0 - $29.1 $18 Million - $25 Million
857,904 New
857,904 $19 Million

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.47B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Casdin Capital, LLC Portfolio

Follow Casdin Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Casdin Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Casdin Capital, LLC with notifications on news.